La Torre J - Search Results

1

Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.

Mattion N, Goris N, Willems T, Robiolo B, Maradei E, Beascoechea CP, Perez A, Smitsaart E, Fondevila N, Palma E, De Clercq K, La Torre J. Mattion N, et al. Among authors: la torre j. Vaccine. 2009 Jan 29;27(5):741-7. doi: 10.1016/j.vaccine.2008.11.026. Epub 2008 Nov 27. Vaccine. 2009. PMID: 19041355

2

Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.

Maradei E, Perez Beascoechea C, Malirat V, Salgado G, Seki C, Pedemonte A, Bonastre P, D'Aloia R, La Torre JL, Mattion N, Rodríguez Toledo J, Bergmann IE. Maradei E, et al. Among authors: la torre jl. Vaccine. 2011 Oct 26;29(46):8230-40. doi: 10.1016/j.vaccine.2011.08.120. Epub 2011 Sep 10. Vaccine. 2011. PMID: 21911020

3

Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region.

Maradei E, Malirat V, Beascoechea CP, Benitez EO, Pedemonte A, Seki C, Novo SG, Balette CI, D'Aloia R, La Torre JL, Mattion N, Toledo JR, Bergmann IE. Maradei E, et al. Vet Microbiol. 2013 Mar 23;162(2-4):479-490. doi: 10.1016/j.vetmic.2012.10.035. Epub 2012 Nov 7. Vet Microbiol. 2013. PMID: 23182909

4

Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test.

Goris N, Maradei E, D'Aloia R, Fondevila N, Mattion N, Perez A, Smitsaart E, Nauwynck HJ, La Torre J, Palma E, De Clercq K. Goris N, et al. Among authors: la torre j. Vaccine. 2008 Jun 25;26(27-28):3432-7. doi: 10.1016/j.vaccine.2008.04.034. Epub 2008 May 5. Vaccine. 2008. PMID: 18499310

5

Foot-and-mouth disease polyvalent oil vaccines inoculated repeteadly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays.

Espinoza AM, Maradei E, Mattion N, Cadenazzi G, Maddonni G, Robiolo B, La Torre J, Bellinzoni R, Smitsaart E. Espinoza AM, et al. Among authors: la torre j. Vaccine. 2004 Nov 15;23(1):69-77. doi: 10.1016/j.vaccine.2004.05.007. Vaccine. 2004. PMID: 15519709

6

Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.

Robiolo B, Seki C, Fondevilla N, Grigera P, Scodeller E, Periolo O, La Torre J, Mattion N. Robiolo B, et al. Among authors: la torre j. Vaccine. 2006 Feb 13;24(7):997-1008. doi: 10.1016/j.vaccine.2005.08.071. Epub 2005 Sep 7. Vaccine. 2006. PMID: 16171905

7

Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies.

Seki C, Robiolo B, Periolo O, Iglesias M, D'Antuono A, Maradei E, Barros V, La Torre J, Mattion N. Seki C, et al. Among authors: la torre j. Vet Microbiol. 2009 Jan 13;133(3):239-51. doi: 10.1016/j.vetmic.2008.07.011. Epub 2008 Jul 26. Vet Microbiol. 2009. PMID: 18774662

8

Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.

Maradei E, La Torre J, Robiolo B, Esteves J, Seki C, Pedemonte A, Iglesias M, D'Aloia R, Mattion N. Maradei E, et al. Among authors: la torre j. Vaccine. 2008 Dec 2;26(51):6577-86. doi: 10.1016/j.vaccine.2008.09.033. Vaccine. 2008. PMID: 18835312

9

Quantitative single serum-dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and expected protection against foot-and-mouth disease virus in vaccinated cattle.

Robiolo B, La Torre J, Duffy S, Leon E, Seki C, Torres A, Mattion N. Robiolo B, et al. Among authors: la torre j. J Virol Methods. 2010 Jun;166(1-2):21-7. doi: 10.1016/j.jviromet.2010.02.011. Epub 2010 Feb 17. J Virol Methods. 2010. PMID: 20170683

10

Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests.

Robiolo B, La Torre J, Maradei E, Beascoechea CP, Perez A, Seki C, Smitsaart E, Fondevila N, Palma E, Goris N, De Clercq K, Mattion N. Robiolo B, et al. Among authors: la torre j. Vaccine. 2010 Aug 31;28(38):6235-41. doi: 10.1016/j.vaccine.2010.07.012. Epub 2010 Jul 17. Vaccine. 2010. PMID: 20643090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters